# Systematic Review and Meta‐Analysis of Short‐ and Long‐Term Outcomes Following Natural Orifice Specimen Extraction for Colon Cancer

**Authors:** Daichi Kitaguchi, Antonello Forgione, Mariano Giménez, Tatsuya Oda, Jacques Marescaux

PMC · DOI: 10.1002/ags3.70096 · 2025-10-11

## TL;DR

This study finds that natural orifice specimen extraction (NOSE) in colon cancer surgery reduces recovery time and complications without affecting long-term cancer outcomes.

## Contribution

The study provides the first systematic review and meta-analysis comparing NOSE with conventional laparoscopic surgery for colon cancer.

## Key findings

- NOSE surgery reduces intraoperative blood loss and postoperative complications compared to conventional methods.
- Patients with NOSE recover faster, with shorter hospital stays and quicker return to normal bowel function.
- Oncological outcomes like recurrence rates are similar between NOSE and conventional laparoscopic surgery.

## Abstract

Natural orifice specimen extraction (NOSE) in colon cancer surgery raises concerns about intra‐abdominal infection, peritoneal seeding, and local recurrence due to possible tumor cell implantation. This systematic review and meta‐analysis compares complete intracorporeal resection with NOSE versus conventional laparoscopic colon resection, focusing on short‐term outcomes and long‐term oncological safety.

A systematic literature search was conducted for English‐language human studies published until April 2025. Meta‐analyses were performed. They evaluated postoperative outcomes that included operative time, intraoperative blood loss, overall morbidity, severe morbidity, time to first flatus, and length of hospital stay. Oncological outcomes included local and overall recurrence rates.

A total of 15 studies met the inclusion criteria, comprising 3 randomized controlled trials and 12 retrospective studies, involving 1683 patients, 733 in the NOSE group and 950 in the conventional group. Pooled analyses demonstrated significantly reduced intraoperative blood loss, lower overall postoperative morbidity, and shorter time to first flatus and postoperative hospital stay in the NOSE group. However, operative time was significantly longer in the NOSE group. The average of median follow‐up periods across studies was 38.9 months, and no significant differences were observed between the two groups in terms of oncological outcomes.

This study supports NOSE as a practical and effective surgical approach in selected patients with colon cancer. It offers significant benefits, including fewer postoperative complications and faster patient recovery, while maintaining oncological outcomes comparable to conventional techniques. NOSE should be considered in clinical practice, tailored to patient preferences and individual clinical factors.

This systematic review and meta‐analysis compares complete intracorporeal colon resection with natural orifice specimen extraction (NOSE) versus conventional laparoscopic resection requiring a small abdominal incision.The analysis evaluates both short‐term postoperative outcomes and long‐term oncological results.Findings support NOSE as a safe and effective approach for selected colon cancer patients, offering reduced postoperative complications and faster recovery, without compromising oncological efficacy.

This systematic review and meta‐analysis compares complete intracorporeal colon resection with natural orifice specimen extraction (NOSE) versus conventional laparoscopic resection requiring a small abdominal incision.

The analysis evaluates both short‐term postoperative outcomes and long‐term oncological results.

Findings support NOSE as a safe and effective approach for selected colon cancer patients, offering reduced postoperative complications and faster recovery, without compromising oncological efficacy.

## Linked entities

- **Diseases:** colon cancer (MONDO:0002032)

## Full-text entities

- **Diseases:** colonic neoplasms (MESH:D003110), injury to the epigastric artery (MESH:C537170), I. (MESH:D006969), obesity (MESH:D009765), sigmoid colon cancer (MESH:D012811), rectal cancer (MESH:D012004), Blood loss (MESH:D016063), T4 tumors (MESH:D009369), postoperative pain (MESH:D010149), NOSE (MESH:D012893), incisional hernias (MESH:D000069290), inflammation (MESH:D007249), SSI (MESH:D013530), abdominal (MESH:D000007), infection (MESH:D007239), postoperative complications (MESH:D011183), Colon Cancer (MESH:D015179), metastases (MESH:D009362)
- **Chemicals:** NOSE (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12962031/full.md

---
Source: https://tomesphere.com/paper/PMC12962031